[Federal Register Volume 59, Number 72 (Thursday, April 14, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-9043]


[[Page Unknown]]

[Federal Register: April 14, 1994]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
[Docket No. 94N-0112]

 

Drug Export; PHOTOPLEX PlusTM Broad Spectrum Sunscreen 
Lotion; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
that appeared in the Federal Register of March 29, 1994 (59 FR 14627). 
The document announced that Allergan Herbert, Division of Allergan, 
Inc., had filed an application requesting approval for the export of 
the human drug PHOTOPLEX PlusTM Broad Spectrum Sunscreen lotion to 
Canada. The document was published with an inadvertent typographical 
error. This document corrects that error.

FOR FURTHER INFORMATION CONTACT: James E. Hamilton, Center for Drug 
Evaluation and Research (HFD-313), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, 301-594-2073.
    In FR Doc. 94-7246, appearing on page 14627, in the Federal 
Register of Tuesday, March 29, 1994, the following correction is made:
    On page 14627, in the third column, in the title of the document, 
the word ``PHOTOLEX'' is corrected to read ``PHOTOPLEX''.


    Dated: April 8, 1994.
David B. Barr,
Deputy Director, Office of Compliance, Center for Drug Evaluation 
Research.
[FR Doc. 94-9043 Filed 4-13-94; 8:45 am]
BILLING CODE 4160-01-F